Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples